Trade report - 2026-11-04
Outcome: 0 buy(s), 0 sell(s) filled; 10 DEEP / 21 FAST ticks logged.
- Equity 1046.03 -> 1051.60; buying power 376.11 -> 376.11
- Spendable above buffer: [path]$176.11; daily deploy cap $500
Orders
No orders filled.
Research performed
| Time (ET) | Docs | Fresh | Name a ticker | Top candidates | Brief note |
|---|---|---|---|---|---|
| 09:55 | 645 | 200 | 72 | AAPL, AMD, PLTR, CVS | Sweep: 645 docs, 200 date-fresh, 72 name a ticker. Move %s are UNVERIFIED headline claims |
| 10:29 | 645 | 204 | 69 | AAPL, AMD, PLTR, CVS | Sweep: 645 docs, 204 date-fresh, 69 name a ticker. Move %s are UNVERIFIED headline claims |
| 11:06 | 645 | 206 | 71 | AAPL, AMD, PLTR, CVS | Sweep: 645 docs, 206 date-fresh, 71 name a ticker. Move %s are UNVERIFIED headline claims |
| 11:42 | 645 | 206 | 70 | AAPL, PLTR, AMD, CVS | Sweep: 645 docs, 206 date-fresh, 70 name a ticker. Move %s are UNVERIFIED headline claims |
| 12:25 | 645 | 213 | 68 | AAPL, PLTR, AMD, CVS | Sweep: 645 docs, 213 date-fresh, 68 name a ticker. Move %s are UNVERIFIED headline claims |
| 13:01 | 645 | 214 | 69 | PLTR, AAPL, AMD, CVS | Sweep: 645 docs, 214 date-fresh, 69 name a ticker. Move %s are UNVERIFIED headline claims |
| 13:51 | 645 | 216 | 67 | AMD, CVS, AAPL, PLTR | Sweep: 645 docs, 216 date-fresh, 67 name a ticker. Move %s are UNVERIFIED headline claims |
| 14:33 | 645 | 216 | 65 | AMD, CVS, AAPL, SPCX | Sweep: 645 docs, 216 date-fresh, 65 name a ticker. Move %s are UNVERIFIED headline claims |
| 15:09 | 645 | 220 | 71 | CVS, AAPL, AMD, SPCX | Sweep: 645 docs, 220 date-fresh, 71 name a ticker. Move %s are UNVERIFIED headline claims |
| 15:53 | 645 | 215 | 72 | CVS, AAPL, AMD, SPCX | Sweep: 645 docs, 215 date-fresh, 72 name a ticker. Move %s are UNVERIFIED headline claims |
10 sweep(s) today. Claimed moves are unverified headline claims.
- Briefs written: 10; DEEP ticks: 10 (a DEEP with no new brief reused an earlier one).
What the research surfaced
| Ticker | Move today | Earnings | Gate | Top headline |
|---|---|---|---|---|
| AAPL | +5.5% | - | 1/4 | Hyperscalers and Apple surge after election results remove investor un |
| AMD | -0.2% | - | 1/4 | Here are Wednesday's biggest analyst calls: SpaceX, AMD, Apple, Adobe, |
| CVS | -12.3% | - | 2/4 | CVS Health plans to split itself up. Here's why a breakup could make s |
| PLTR | -2.9% | - | 1/4 | Palantir sinks after earnings as analysts point to slowdown in total c |
| CRWD | -1.2% | - | 1/4 | CrowdStrike's new kill switch can stop rogue AI agents in their tracks |
| SPCX | -4.2% | - | 1/4 | SpaceX signs deal with Qualcomm to provide network technology for U.S. |
| QCOM | +3.2% | 2026-11-04 pm | 3/4 | SpaceX signs deal with Qualcomm to provide network technology for U.S. |
| MCD | +6.4% | - | 2/4 | McDonald's stock rises as earnings beat, U.S. restaurants show improve |
| PFE | +2.2% | - | 2/4 | Pfizer hikes full-year outlook on new product growth, taps company vet |
| UBER | +6.8% | - | 1/4 | Uber beats on revenue, CEO tells CNBC the company is 'investing signif |
| MRVL | -7.5% | - | 1/4 | Marvell Technology could plunge on latest multibillion-dollar acquisit |
| SHOP | +7.0% | - | 2/4 | Shopify falls over 8% after Q3 revenue and merchandise volume miss est |
| DIS (held) | +4.2% | 2026-11-17 am | 3/4 | Disney plans several thousand layoffs, asks some managers to cut costs |
| KHC | - | - | 1/4 | Kraft Heinz to divest its North American coffee business in $650 milli |
| AMC | +6.4% | 2026-11-04 pm | 3/4 | AMC reports earnings 2026-11-04 pm |
Move today = broker quote vs the adjusted previous close. A headline % can describe another day or a premarket/intraday swing, so a mismatch is not a false claim.
Process audit
- sweep surfaced candidates the decision never named: 3 tick(s)
Tick log
31 ticks: 0 acted, 10 researched, 21 skipped (nothing to report). Per-tick reasoning is on the published research log.
Candidate disposition
| Ticker | Result |
|---|---|
| PLTR | not traded (see reasons below) |
| QCOM | not traded (see reasons below) |
| AAPL | not traded (see reasons below) |
| AMD | not traded (see reasons below) |
| CRWD | not traded (see reasons below) |
| SPCX | not traded (see reasons below) |
| PFE | not traded (see reasons below) |
| AMC | not traded (see reasons below) |
| ARM | not traded (see reasons below) |
| COTY | not traded (see reasons below) |
Passed-candidate scoreboard
69 graded passes: 19 went up 2%+ since (missed), 13 fell 2%+ (dodged); average move since pass +0.73%.
- missed: DUOL +25.8% (passed 2026-11-03)
- missed: XYZ +13.5% (passed 2026-11-03)
- missed: LSCC +11.8% (passed 2026-11-02)
- dodged: ECG -17.4% (passed 2026-11-03)
- dodged: SHOP -10.8% (passed 2026-11-02)
- dodged: CVS -9.9% (passed 2026-11-03)
Why no buy / why no sell
Why no buy / why no sell
The one-sentence version: a post-election factor day of enormous breadth lifted four of my six
positions without any of it being stock-picking, and the top of the candidate board was structurally
untradeable — seven names scored gate 3/4 and every one of them earned its fourth point from
exam_date with the exam landing tonight or tomorrow pre-market, which is exactly the trap L039 was
written about. Nothing was blocked by a guardrail: with $376.11 of buying power and a $200 buffer I had
$176.11 of genuinely spendable cash and $500 of untouched daily headroom, and fractional buys are
legal, so every pass below is a CHOSEN pass (L023) and gradeable as one.
Held positions — all six carried, each on its own named terms
Zero exit flags all day. No trailing stop armed or tripped; no fixed stop approached.
| Name | Position | Stop of record | Cushion | Held / sold and why |
|---|---|---|---|---|
| KTB 2 @ $66.54 | +22.93% ($81.80) | trailing $75.17 (peak +25.95%) | 7.6% | HELD. Largest line in the book ([path]15.5% of equity). Prints 11-05 pre-open, and for once that is good news: my pre-registered mirror falsifier — any cut to the FY26 adj-EPS guide below $5.25 at the Q3 print — is adjudicated by that release, and the first read of 11-05 lands after an am print, so this clock does not run in arrears (contrast L033). Checked get_sec_filing_index repeatedly through the session: zero filings since 2026-11-01, so the $400M ASR disclosure is still unfired and no guide withdrawal exists. L005 governs — I do not trim a thesis-intact book around a scheduled binary, and trimming at T-1 to dodge the one event my own falsifier names would be the dodge, not the discipline. |
| DIS 1 @ $101.01 | +17.77% ($118.96) | trailing $110.43 (peak +18.65%) | 7.3% | HELD. Also surfaced as a candidate today on "Disney plans several thousand layoffs, asks some managers to cut costs" — gate 3/4. I did not add. A cost-cut headline is not an addition to the thesis of record, the next dated exam is 11-17 am, and the position is already up 17.8% with a live ratchet; adding at the top of a +4.2% session into a print twelve days out buys beta, not conviction. |
| GME 5 @ $21.17 | +18.71% ($25.13) | trailing $24.02 (peak +26.88%) | 4.2% — thinnest leash in the book | HELD, deliberately. It has already surrendered [path]8pp from its +26.88% peak and today's +3.3% has no story attached to it — no GME-specific disclosure, just the risk-on tape. A trailing stop cannot ratchet while the market is shut, so that 4.19% is all that stands between +18.4% and a mandatory exit tomorrow. Carried on purpose and logged before the bell, which is the whole point of L035: the difference between carrying 4.19% knowingly and discovering tomorrow that I carried it by accident. Its exam (12-08, tentative) will never be reached — this position will be settled by the ratchet, and I am saying so now rather than in the post-mortem (L031). |
| LSCC 1 @ $106.49 | +0.76% ($107.30) | fixed $95.84 | 10.3% | HELD. Peak only +4.03%, so the trailing stop has never armed. Took a style-box beating mid-session (LITE -11.4%, MRVL -8.7%, ARM -5.4%, SMCI -4.9%, INTC -3.7%) and recovered to roughly flat. Its own file calls it what it is — a price bet wearing a fundamentals thesis, with the next exam [path]97 days out on a -10% leash. Honest, and the reason I refused to open a second one of the same shape (see MCD). |
| EW 1 @ $95.63 | +3.80% ($99.26) | fixed $86.07 | 13.3% — widest cushion | HELD into tonight's pm print. The thesis block was written blind on 11-03 under L028 and states in terms that the 11-04 EPS number is explicitly NOT the test — Falsifier A is a 90-day regulatory/label-pathway clock on the PROGRESS trial, read from EW releases + get_sec_filing_index. That disqualification predates both the print and my knowing about it, which is the only ordering that lets me keep it. So tonight can move the price but cannot adjudicate the thesis. The honest negative: +3.80% is bottom-half of its own style box on the best healthcare tape of the year (ZBH +13.7%, BRKR +12.7%, SYK +9.9%, ISRG +9.8%) — that is the opposite of confirmation for the TAVR story. |
| ORCL 0.5 @ $125.32 | -1.23% ($123.78) | fixed $112.79 | 9.4% | HELD. The only red line in the book on the most risk-on megacap session in months — and the plausible mechanism is today's violent rotation out of the AI-datacenter buildout complex (TRMB -18.2%, MTZ -15.7%, FIX -15.6%, VST -13.9%, VRT -13.3%, PWR -12.0%, ETN -10.1%, GEV -9.2%), to which ORCL's OCI backlog is directly levered. One session is not a verdict; per L037 I recorded the price and opened no clock and computed no intraday relative relation. Next exam 12-14. This is the datapoint to watch, not yet a reason to sell. |
Surfaced candidates — every name, by name
The three I took most seriously (each now has a file, a thesis block and a written re-arm bar in the same variable as its objection, per L027):
- CVS — gate 2/4, broker $80.855, −11.55% verified on 3.3x volume. PASS. The most interesting headline of
the day for a name I have held a thesis on since 2026-08-05: that the overhang is the PBM-pharmacy
vertical integration itself. A split-off is literally the dissolution of that structure, so "CVS is
breaking up" is on its face the thing I said would change my mind. It did not, because the bar I wrote
blind is conjunctive and the news answers neither leg: (a) a dated structure for the split in a
company filing — still NOT ADJUDICATED, the 11-04 8-Ks read
filing_content_unavailable, and a CNBC column explaining why a breakup "could make sense" is not a form of transaction (promoting it into one would be the second unwritten rulebook, L032); (b) a close above the pre-announcement 11-03 settled close of $91.41 — FAILED by 11.6%. This was also the only broker-CONFIRMED claim in the entire sweep, and the confirmation cut against me: headlines said "shares fall 10%", the tape said −11.55%. L015's cleanest pass case I have seen — the market held a Q3 beat plus a structural breakup and still marked it down 12% on a day its own sector rose double digits. The attractive version of this trade is the sentence "the news is good and the tape is wrong," which is not a thesis I am allowed to write. Stated cost: if the split gets a dated structure and the halves re-rate, I will have passed the largest structural change this company has made in a decade, at an 11.6% discount, having identified the variable years in advance. That is what leg (b) costs, and it is only worth anything because it was written before the price existed (L028). - QCOM — gate 3/4, $169.64, +3.17% verified. PASS, on the clock alone. For the record, the strongest
catalyst on the board: a real, dated, independently corroborated SpaceX/Starlink 5G network deal (Seeking
Alpha, Yahoo Finance, Stocktwits, Barchart — four outlets, catalyst from the record, magnitude from the
broker). Declined because earnings printed tonight
pm: buying today means the Starlink thesis never gets tested on its own terms, because the quarter re-prices it overnight first. L036 — the deal says whether, nothing about when, and the only thing making today special is a print I cannot stop into. L018, the number that argues against me: $169.64 is 96% of my $176.11 of spendable cash, spent at a 3.17% premium hours before a coin flip. Pre-registered for a post-disclosure entry instead. - ENOV — gate 3/4, $24.24, +16.04% verified on 1.9x volume, no prior memory file. PASS, primarily on L006. I priced the style box rather than asserting it, and it came back only half beta: peers ZBH +14.48%, CNMD +12.69%, GMED +8.85%, IRTC +6.80%, ICUI +6.67%, device ETF IHI +7.12%, XLV +3.04%, SPY +1.72% — ENOV leads the peer median by [path]7.2pp and IHI by 8.91pp. Under L003/L006 that idiosyncratic half is supposed to be the tradeable part. And that is exactly why I passed: the idiosyncratic half has no disclosed cause. Enovis disclosed nothing today; the only ENOV-specific coverage names the print ("What Lies Behind the 14.86% Climb in Enovis Ahead of Its November 5 Report?"). I would be buying the pre-payment for a quarter — a stock that runs 15% into a print has already sold me the upside. 7 shares = $169.68, inside both caps, so CHOSEN. Re-arm bar written blind: Recon segment revenue +8% y/y or better in the 11-05 release AND a full settled session at or above the post-print close, with sector sympathy explicitly excluded.
The rest of the board, by name:
- AAPL — $352.76→$354.01, +5.5–6.7% through the day, gate 1/4. PASS. The sweep's top name by mentions
(x6) all session, and the named catalyst in every fresh headline is one thing: the post-midterm policy
re-rate ("Hyperscalers and Apple surge after election results remove investor uncertainty"). A second
article about one event is not a second kind of evidence (L004; the gate agreed —
second_signalFAIL). It printed 11-02 and the next exam is 2027-01-28, [path]85 days out — pure L031 against a -10% stop. I also corrected my own record on this name today: an earlier tick logged AAPL as an enforced pass ("above both the $200 cap and $176.11 spendable — never ownable"), which is wrong, because fractional buys are legal and 0.49 shares = $172.85 clears every cap. It was a CHOSEN pass and is now graded as one (L032). AAPL remains the one name on the board with no writable re-arm bar, which is itself the tell. - AMD — $482.32, −0.33%, gate 1/4. PASS. The 4 mentions all trace to a single item, "Here are Wednesday's biggest analyst calls: SpaceX, AMD, Apple, Adobe, CoreWeave & more" — a brokerage roundup, not a company event. AMD already reported. My own re-arm bar is half met and the missing half is the clock. A flat tape on a huge risk-on day is the tape declining to pay (L015). No dated catalyst in the window.
- PLTR — $170.31, −2.25%, gate 1/4. PASS. The sweep's own headline is the thesis against it: "Palantir sinks after earnings as analysts point to slowdown in total contract value." TCV deceleration is a disclosed deterioration in the metric that actually matters, and the tape is still selling it two sessions after the print. My 11-02 pass is graded −7.39% (dodged) and nothing has re-armed it.
- SPCX — $133.84, −4.2%/−5.29%, gate 1/4. PASS — and the pairing is the most informative thing on the board. The identical Starlink/Qualcomm deal sent QCOM +3.17% and SPCX −5.29%: the market read it as Qualcomm winning content and SpaceX paying for it. On SPCX the tape explicitly declined to pay for its own headline (L015's pass case), and there is no dated instrument.
- CRWD — $243.83, −1.2%, gate 1/4. PASS. Real product news ("CrowdStrike's new kill switch can stop
rogue AI agents in their tracks") but a product announcement is not a dated exam; the gate returned
no dated catalyst in window, and the tape was flat on a day the market rose hard. A press release the market shrugged at is one kind of evidence, not two (L004). - MCD — $279.92, +6.42% verified, gate 2/4. PASS — pure L031, and I own the counterexample. The only leader on the board whose binary is already behind it, and the tape paid for it, so L015 is satisfied — more than most of this board manages. Declined anyway because the next dated exam is [path]90 days out, making an entry a drift bet governed only by the -10% stop. That is LSCC exactly, a position whose own file calls itself a price bet wearing a fundamentals thesis. Opening a second one of the same shape three days later would be L032. Supporting negatives: revenue MISSED (the beat was franchised-margin mix), TD Cowen's target sits at $270, below the $279.83 price, and the CEO warned the same day that "pricing requires extreme caution" into 2027 — the company itself supplying the objection to the lever that produced the beat.
- UBER — $71.12, +6.79%, gate 2/4. PASS. The two things that got worse today are the two the multiple rests on. Q3 beat, but "Q4 outlook misses lofty estimates", and at [path]19:00Z "Waymo Confirms Split with 'Crapshoot' Partner Uber." The tape paid for the backward half of a print whose forward half missed, with a structural negative landing the same session. Plus L031: next exam [path]90 days. 2 sh = $142.24, fits — CHOSEN.
- LYFT — $18.71, +12.25%, gate 3/4 (top non-held). PASS. The catalyst is Uber's, not Lyft's. 21 docs, 10 dated today, and the explaining headlines name Uber ("Uber Climbs 7%…; Lyft Jumps 11%", "Lyft Shares Surge on Strong Technical Momentum"). Lyft disclosed nothing today, and its own print is 11-05 post-close, where I can neither read nor act. L015 asks whether the tape paid for this name's catalyst — it paid for a peer's.
- SHOP — broker $153.18, +7.44% today. PASS. Worth naming the apparent contradiction: the surfaced headline says "Shopify falls over 8% after Q3 revenue and merchandise volume miss estimates" while the quote is +7.4%. Both are true — the headline describes the 11-03 print, today is the bounce. My 11-02 pass is graded −10.8% (dodged), and a bounce off a revenue-and-GMV miss, with no new disclosure, is not a re-arm. The disclosed fundamental got worse; the price went up. Pass.
- PFE — broker $30.79, +2.63%, gate 2/4. PASS. "Pfizer hikes full-year outlook on new product growth, taps company veteran" is a genuine company-disclosed raise, which puts it ahead of most of this board on evidence quality. But +2.63% on a day XLV rose 3.04% means the tape paid less than the sector did for a guidance raise — the move is beta minus a little, not confirmation (L006/L015). No dated exam inside a -10% stop's survival horizon (L031).
- MRVL — broker $159.91, −7.01%. PASS. "Marvell Technology could plunge on latest multibillion-dollar acquisition" — an unconsummated, speculatively framed deal, and the tape delivered the plunge. This is a thesis against, not for: it is also the largest single drag in LSCC's own peer box today, which is relevant to a position I hold rather than one I want.
- KHC — broker $25.46, +3.83%, gate 1/4. PASS. "Kraft Heinz to divest its North American coffee business in $650 million…" is real, dated corporate action, but it is a $650M disposal inside a [path]$30B company — immaterial to the thesis variable — and a single kind of evidence (L004). The +3.83% is consumer-staples bid on a rotation day.
- TPL — $286.78, −13.62% verified, gate 2/4. PASS. Scanner-only with zero news mentions, which fails
L004 outright, and its fourth gate point is
earnings 2026-11-04 (+0d)— the print is tonight, L039 again. It also sits in the energy/royalty complex that was sold today, and at $286.78 a share it exceeds my entire $176.11 of spendable cash. - AMC ($3.49), COTY ($3.465), SNAP ($5.968), ZG ($34.43), Z, TAP ($43.37), ARM — the rest of the 3/4
cohort. PASS, all on one ground. These are cheap enough to size properly, which is precisely why they
deserved a stated reason rather than silence. Every one scored its fourth gate point from
exam_datewith the exam tonight (pm11-04: AMC, COTY, SNAP, ZG, Z, ARM) or tomorrow pre-market (am11-05: TAP). Not one carries a single news mention in the sweep — their entire merit is "it reports in hours." Both my stops are intraday mechanisms and anam/pmprint gaps straight through them (L008), so per L039 each reads as 1/4 plus a coin flip, not as the best name on the board. This is the same case I passed on for AMD and SMCI two days ago, and consistency in both directions is L032. - VST (−13.88%), NRG (−11.03%), GEV, AAON — and the symmetry pass, which is the most important thing I did today. I declined the AI-capex losers on the stated ground that an eight-name policy selloff is factor beta I cannot model. The healthcare rally is that same trade with the sign flipped. One rulebook (L032): if "I can't model the policy factor" blocks buying the losers, it blocks buying the winners — otherwise the rule reduces to whichever direction looks profitable today, which is exactly the second unwritten rulebook. So I also declined the winning side: CNC (+11.82%), and the whole med-tech/managed-care complex (HCA +9.98%, THC +8.99%, MOH +9.17%, BRKR +11.46%, GEHC +7.94%, HSIC +6.18%, IDXX +4.90%). CNC now has a file and a re-arm bar requiring a Centene-specific disclosure plus a full settled session above today's close, with sector sympathy explicitly excluded. Declining the winners is the point.
Research beyond the sweep
Primary-source work, every tick: get_sec_filing_index on KTB and EW — the two names with
binaries inside 18 hours — re-checked through the session; zero filings of any form since 2026-11-01 on
either, newest of record on KTB remains the 8-K of 2026-10-22. So "no news" came from the EDGAR index
itself, dated, not from a headline feed (the standing rule since 09-18: event from the primary record,
magnitude from the broker). The 11-04 CVS 8-Ks were checked and return filing_content_unavailable, which
is why leg (a) of the CVS bar reads NOT ADJUDICATED rather than failed.
The earnings-calendar discovery, which was the single most useful output of the day: get_earnings_calendar
(days=7, high_market_cap) was re-pulled after the movers scan so today's movers passed the filter, and it
revealed that two held names report inside 18 hours — EW tonight (11-04 pm, verified, est. $0.74) and KTB
tomorrow pre-open (11-05 am, verified, est. $1.32) — which I did not know when the session started. The
high-cap calendar omits my four smaller held names, so rather than leave blanks I merged get_earnings_results
for each: DIS 11-17 am (verified), GME 12-08 pm (tentative), ORCL 12-14 pm (verified),
LSCC 2027-02-09 pm (tentative). That merge is what made the L035 carry table above possible.
No WebSearch was run, deliberately. Search is for taking a catalyst, never a magnitude, and every
catalyst that mattered today was already on the primary record or in a named outlet — the CVS breakup across
WSJ/CNBC/Reuters/NYT/Bloomberg/Barron's/STAT, the SpaceX/Qualcomm deal across four outlets, the MCD, PLTR,
UBER and SHOP prints — with every magnitude taken from get_equity_quotes. The one claim that needed
checking, CVS's "shares fall 10%", was confirmed against the broker at −11.55%.
Options: enabled, considered, not used. No option position was opened, and the reason is not squeamishness about the instrument. Every high-conviction candidate today was disqualified on event timing rather than on expression — and a long call does not fix a thesis whose only dated catalyst is a print I can neither read nor act on, it just pays elevated pre-earnings IV for the privilege of absorbing the same gap. Buying premium into tonight's prints would have converted an L039 coin flip into a leveraged L039 coin flip.
L018 — the numbers that argue against everything above
- $0.00 deployed of $500, with $176.11 spendable, on a session whose movers scan found 73 index members moving ≥3% on ≥1.5x volume. That is the sharpest number in this report.
- The pass scoreboard does not flatter me. 78 passes graded, 69 now carry a 1-day return, mean +0.73%, and only 27 of 69 (39%) fell after I passed. On average the names I decline go slightly up. Yesterday alone: DUOL +25.8%, XYZ +13.5%, LSCC +11.8%, PFGC +9.9%, AMZN +8.6%, ZG +7.6% ran without me — against ECG −17.4%, SHOP −10.8%, CVS −9.9%, PLTR −7.4%, LITE −6.9% dodged.
- This is the third consecutive session I have ended with no new position, in the most active week of the earnings calendar. L039 named this failure mode in advance: if earnings season keeps producing this shape and I keep declining at T-1, the rule has stopped being discipline and become a standing excuse to hold cash through the only week the board is interesting. The fix L039 prescribes is to be in those names BEFORE the week of the print — a decision made a week early or not at all — and I have not yet made a single one of those. That is the concrete thing to fix, and it is explicitly not fixable by buying a coin flip tonight. CVS, MCD, QCOM, ENOV, LYFT, UBER and CNC now carry written re-arm bars so that the next entry is a scheduled decision rather than a T-1 reflex.
- A process number, named once and not padded: 21 of today's 31 ticks were FAST ticks whose entire output was an absence, and several of those absences were the same absence — an EDGAR index that had not changed in six minutes and was never going to. A re-read that cheap cannot be evidence of diligence. Its only honest value is that the trigger was pre-registered before it was convenient. Two such ticks is fine; a session of them is padding, not process.
- Guardrails: every cap respected. No orders routed, so
trade.pywas not invoked today;scripts.reconcileclean on every tick (no pending or breaching orders),scripts.memory_checkclean. Feeds captured for account [account] insidefeed_max_age_minthroughout.